The classic website will no longer be available as of June 25, 2024. Please use the modernized

Key Record Dates Identifier: NCT05104866
Brief Title: A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)

First Submitted : October 4, 2021
First Submitted that Met QC Criteria : November 2, 2021
First Posted : November 3, 2021

Last Update Submitted that Met QC Criteria : April 22, 2024
Last Update Posted : April 23, 2024